Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infection

Heart and Vessels
Luigi MoschiniGian Battista Danzi

Abstract

Most of the drugs associations that have been used to treat patients with SARS-CoV-2 infection increase the risk of prolongation of the corrected QT interval (QTc). To evaluate the effects of an association therapy of hydroxychloroquine (HY) plus ritonavir/darunavir (RD) or azithromycin (AZ) on QTc intervals. At the beginning of COVID-19 pandemic patients admitted to our hospital were treated with the empiric association of HY/RD; one week later the therapeutic protocol was modified with the combination of HY/AZ. Patients underwent an ECG at baseline, then 3 and 7 days after starting therapy. We prospectively enrolled 113 patients (61 in the HY/RD group-52 in the HY/AZ group). A significant increase in median QTc was reported after seven days of therapy in both groups: from 438 to 452 ms in HY/RD patients; from 433 to 440 ms in HY/AZ patients (p = 0.001 for both). 23 patients (21.2%) had a QTc > 500 ms at 7 days. The risk of developing a QTc > 500 ms was greater in patients with prolonged baseline QTc values (≥ 440 ms for female and ≥ 460 ms for male patients) (OR 7.10 (95% IC 1.88-26.81); p = 0.004) and in patients with an increase in the QTc > 40 ms 3 days after onset of treatment (OR 30.15 (95% IC 6.96-130.55); p = 0.001). O...Continue Reading

References

Feb 10, 2010·Circulation·Barbara J DrewUNKNOWN American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology, the Council on Cardiovascular
May 18, 2012·The New England Journal of Medicine·Wayne A RayC Michael Stein
Feb 24, 2018·Current Clinical Pharmacology·Cecilia Villa EtchegoyenGuillermo Di Girolamo
Mar 3, 2020·JAMA Internal Medicine·Timothy F SimpsonZian H Tseng
Mar 10, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Xueting YaoDongyang Liu
Mar 19, 2020·The New England Journal of Medicine·Bin CaoChen Wang
Mar 25, 2020·International Journal of Antimicrobial Agents·Philippe GautretDidier Raoult
Apr 2, 2020·Annals of Internal Medicine·Jinoos Yazdany, Alfred H J Kim
Apr 28, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Adarsh BhimrajYngve Falck-Ytter
Mar 30, 2020·MedRxiv : the Preprint Server for Health Sciences·L. HuYouping Deng

❮ Previous
Next ❯

Citations

Feb 24, 2021·AIDS Research and Human Retroviruses·Jovana MilicGiovanni Guaraldi
Jun 3, 2021·Journal of Cardiovascular Development and Disease·Angelos Arfaras-MelainisRobert T Faillace
Nov 19, 2021·European Heart Journal·UNKNOWN Task Force for the management of COVID-19 of the European Society of Cardiology

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.